XTL Biopharmaceuticals Ltd.
XTL Biopharmaceuticals Ltd. (XTLB) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · XTLB · as of Jun 9, 2026
Key Statistics
Explore XTL Biopharmaceuticals Ltd. Data
xtlb stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 100.0%
Competitors & Peers
xtlb competitorsXTLB
AIM
CYCN
ENSC
KALA
KTTAStock Performance
Full HistoryAbout XTL Biopharmaceuticals Ltd.
XTL Biopharmaceuticals Ltd. is a biopharmaceutical firm dedicated to identifying and advancing novel drug therapies for autoimmune conditions. Its primary investigational compound, hCDR1, is poised to…
what is xtl biopharmaceuticals ltd. · xtlb stock overview · xtl biopharmaceuticals ltd. company profile · who is xtl biopharmaceuticals ltd. ceo · xtlb NASDAQ · xtl biopharmaceuticals ltd. headquarters · xtl biopharmaceuticals ltd. business segments
About Stock Overview & Key Data
XTL Biopharmaceuticals Ltd. (XTLB) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Sep 1, 2005. As of the latest trading session, XTLB stock price is $2.23, with a market capitalization of $5.3M. The stock has returned -55.40% over the past 12 months and -3.88% year-to-date.
According to 2 Wall Street analysts, the consensus rating for XTL Biopharmaceuticals Ltd. stock is Buy, with an average 12-month price target of $—. In fiscal year 2024, XTL Biopharmaceuticals Ltd. reported revenue of $451000.00 and net income of -$1.0M. For detailed data — including XTL Biopharmaceuticals Ltd. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, XTL Biopharmaceuticals Ltd. (XTLB) stock price is $2.23. The stock is traded on NASDAQ under the ticker symbol XTLB. The 52-week range is $2.02 – $10.28.